• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血清丁酰胆碱酯酶的组氨酸修饰

Histidine modification of human serum butyrylcholinesterase.

作者信息

Cengiz D, Cokuğraş A N, Kilinç K, Tezcan E F

机构信息

Department of Biochemistry, Faculty of Medicine, Hacettepe University, Anhara, Turkey.

出版信息

Biochem Mol Med. 1997 Jun;61(1):52-7. doi: 10.1006/bmme.1997.2578.

DOI:10.1006/bmme.1997.2578
PMID:9232197
Abstract

The effects of histidine-modifying reagents on human serum butyrylcholinesterase (BChE) were investigated. The commercially available enzyme was further purified by chromatography on a Sepharose CI-6B column prior to use. In the modification studies, we found that the histidine-specific reagents tosylphenylalanine chloromethyl ketone (TPCK) and tosyllysine chloromethyl ketone (TLCE) did not modify the enzyme; however, they inhibited the enzyme reversibly. The kinetic parameters of enzyme inhibition calculated were alpha = 10.8, beta = 0.26, and Ki = 0.016 mM for TPCK. TLCK inhibition gave similar kinetic behavior, with alpha = 41.6, beta = 0.065, and Ki = 0.039 mM. Tosyllysine, an analog of TLCK, did not inhibit the enzyme. Removal of TPCK and TLCK by dialysis resulted in significant reactivation of the enzyme. From kinetic studies, it was found that the inhibitions were hyperbolic mixed-type inhibitions. We concluded that the reagents competed with substrate for hydrophobic binding sites and inhibited the enzyme reversibly. On the other hand, in the modification studies with diethyl pyrocarbonate (DPC), it was observed that inactivation of the enzyme was irreversible and time-dependent. In the protection studies, the activity of the enzyme was partially protected from inactivation by DPC even at a 50 mM concentration of butyrylthiocholine. The results indicate that DPC modifies some essential histidine side chains in BChE, including the functional histidyl residue found at the active site.

摘要

研究了组氨酸修饰试剂对人血清丁酰胆碱酯酶(BChE)的影响。市售酶在使用前通过Sepharose CI - 6B柱色谱进一步纯化。在修饰研究中,我们发现组氨酸特异性试剂甲苯磺酰苯丙氨酸氯甲基酮(TPCK)和甲苯磺酰赖氨酸氯甲基酮(TLCK)不会修饰该酶;然而,它们可逆地抑制该酶。计算得到的TPCK酶抑制动力学参数为α = 10.8,β = 0.26,Ki = 0.016 mM。TLCK抑制表现出类似的动力学行为,α = 41.6,β = 0.065,Ki = 0.039 mM。TLCK的类似物甲苯磺酰赖氨酸不抑制该酶。通过透析去除TPCK和TLCK导致酶显著重新激活。从动力学研究发现,这些抑制是双曲线混合型抑制。我们得出结论,这些试剂与底物竞争疏水结合位点并可逆地抑制该酶。另一方面,在用焦碳酸二乙酯(DPC)进行的修饰研究中,观察到酶的失活是不可逆的且与时间相关。在保护研究中,即使在丁酰硫代胆碱浓度为50 mM时,该酶的活性也部分受到DPC失活的保护。结果表明DPC修饰了BChE中一些必需的组氨酸侧链,包括在活性位点发现的功能性组氨酸残基。

相似文献

1
Histidine modification of human serum butyrylcholinesterase.人血清丁酰胆碱酯酶的组氨酸修饰
Biochem Mol Med. 1997 Jun;61(1):52-7. doi: 10.1006/bmme.1997.2578.
2
Do alkylating agents modify the histidine residue of the desensitized butyrylcholinesterase?烷化剂会修饰脱敏丁酰胆碱酯酶的组氨酸残基吗?
Protein J. 2004 Nov;23(8):495-500. doi: 10.1007/s10930-004-7876-0.
3
The serine protease inhibitors, tosylphenylalanine chloromethyl ketone and tosyllysine chloromethyl ketone, potently inhibit pp70s6k activation.丝氨酸蛋白酶抑制剂甲苯磺酰苯丙氨酸氯甲基酮和甲苯磺酰赖氨酸氯甲基酮可有效抑制pp70s6k的激活。
J Biol Chem. 1996 Sep 27;271(39):23650-2. doi: 10.1074/jbc.271.39.23650.
4
Study of the peptidasic site of cholinesterase: preliminary results.胆碱酯酶肽段位点的研究:初步结果。
FEBS Lett. 1985 Mar 25;182(2):493-8. doi: 10.1016/0014-5793(85)80361-6.
5
N-alpha-Tosyl-L-lysine chloromethyl ketone and N-alpha-tosyl-L-phenylalanine chloromethyl ketone inhibit protein kinase C.N-α-对甲苯磺酰-L-赖氨酸氯甲基酮和N-α-对甲苯磺酰-L-苯丙氨酸氯甲基酮可抑制蛋白激酶C。
FEBS Lett. 1985 Oct 14;190(2):342-4. doi: 10.1016/0014-5793(85)81315-6.
6
Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-kappa B.氯甲基酮通过阻止核因子-κB的激活来阻断小鼠巨噬细胞中一氧化氮合酶的诱导。
J Immunol. 1995 May 1;154(9):4741-8.
7
Tosylphenylalanine chloromethyl ketone inhibits TNF-alpha mRNA synthesis in the presence of activated NF-kappa B in RAW 264.7 macrophages.
Immunology. 1997 Oct;92(2):267-73. doi: 10.1046/j.1365-2567.1997.00335.x.
8
Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) are potent inhibitors of activated caspase proteases.丝氨酸蛋白酶抑制剂N-α-甲苯磺酰-L-赖氨酰氯甲基酮(TLCK)和N-甲苯磺酰-L-苯丙氨酰氯甲基酮(TPCK)是活化半胱天冬酶蛋白酶的有效抑制剂。
J Cell Biochem. 2008 Apr 1;103(5):1646-56. doi: 10.1002/jcb.21550.
9
Studies on the mechanism of hyaluronate lyase action.
Connect Tissue Res. 1975;3(2):135-9. doi: 10.3109/03008207509152171.
10
The serine protease inhibitors TLCK and TPCK inhibit the in vitro immortalization of primary human keratinocytes by HPV-18 DNA.丝氨酸蛋白酶抑制剂TLCK和TPCK可抑制人原代角质形成细胞被人乳头瘤病毒18型(HPV-18)DNA体外永生化。
Oncogene. 1996 Oct 3;13(7):1545-8.